Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation

Background Australian clinical trials are planned to evaluate medicinal cannabis in a range of clinical contexts. Aims To explore the preferences, attitudes and beliefs of patients eligible and willing to consider participation in a clinical trial of medicinal cannabis for poor appetite and appetite...

Full description

Saved in:

Bibliographic Details
Published in	Internal medicine journal Vol. 46; no. 11; pp. 1269 - 1275
Main Authors	Luckett, T., Phillips, J., Lintzeris, N., Allsop, D., Lee, J., Solowij, N., Martin, J., Lam, L., Aggarwal, R., McCaffrey, N., Currow, D., Chye, R., Lovell, M., McGregor, I., Agar, M.
Format	Journal Article
Language	English
Published	Melbourne John Wiley & Sons Australia, Ltd 01.11.2016
Subjects	Adolescent Adult Aged Aged, 80 and over anorexia Anorexia - drug therapy Appetite - drug effects attitude Australia cancer cannabis clinical trial Clinical Trials as Topic Cross-Sectional Studies Female Health Knowledge, Attitudes, Practice Humans Logistic Models Male Medical Marijuana - administration & dosage Medical Marijuana - therapeutic use Middle Aged Neoplasms - complications Patient Participation Patient Preference Self Report Young Adult clinical trial cannabis cancer anorexia attitude
Online Access	Get full text
ISSN	1444-0903 1445-5994
DOI	10.1111/imj.13224

Cover

Abstract	Background Australian clinical trials are planned to evaluate medicinal cannabis in a range of clinical contexts. Aims To explore the preferences, attitudes and beliefs of patients eligible and willing to consider participation in a clinical trial of medicinal cannabis for poor appetite and appetite‐related symptoms from advanced cancer. Methods A cross‐sectional anonymous survey was administered from July to December 2015 online and in eight adult outpatient palliative care and/or cancer services. Respondents were eligible if they were ≥18 years, had advanced cancer and poor appetite/taste problems/weight loss and might consider participating in a medicinal cannabis trial. Survey items focused on medicinal rather than recreational cannabis use and did not specify botanical or pharmaceutical products. Items asked about previous medicinal cannabis use and preferences for delivery route and invited comments and concerns. Results There were 204 survey respondents, of whom 26 (13%) reported prior medicinal cannabis use. Tablets/capsules were the preferred delivery mode (n = 144, 71%), followed by mouth spray (n = 84, 42%) and vaporiser (n = 83, 41%). Explanations for preferences (n = 134) most commonly cited convenience (n = 66; 49%). A total of 82% (n = 168) of respondents indicated that they had no trial‐related concerns, but a small number volunteered concerns about adverse effects (n = 14) or wanted more information/advice (n = 8). Six respondents volunteered a belief that cannabis might cure cancer, while two wanted assurance of efficacy before participating in a trial. Conclusion Justification of modes other than tablets/capsules and variable understanding about cannabis and trials will need addressing in trial‐related information to optimise recruitment and ensure that consent is properly informed.
AbstractList	Background Australian clinical trials are planned to evaluate medicinal cannabis in a range of clinical contexts. Aims To explore the preferences, attitudes and beliefs of patients eligible and willing to consider participation in a clinical trial of medicinal cannabis for poor appetite and appetite‐related symptoms from advanced cancer. Methods A cross‐sectional anonymous survey was administered from July to December 2015 online and in eight adult outpatient palliative care and/or cancer services. Respondents were eligible if they were ≥18 years, had advanced cancer and poor appetite/taste problems/weight loss and might consider participating in a medicinal cannabis trial. Survey items focused on medicinal rather than recreational cannabis use and did not specify botanical or pharmaceutical products. Items asked about previous medicinal cannabis use and preferences for delivery route and invited comments and concerns. Results There were 204 survey respondents, of whom 26 (13%) reported prior medicinal cannabis use. Tablets/capsules were the preferred delivery mode (n = 144, 71%), followed by mouth spray (n = 84, 42%) and vaporiser (n = 83, 41%). Explanations for preferences (n = 134) most commonly cited convenience (n = 66; 49%). A total of 82% (n = 168) of respondents indicated that they had no trial‐related concerns, but a small number volunteered concerns about adverse effects (n = 14) or wanted more information/advice (n = 8). Six respondents volunteered a belief that cannabis might cure cancer, while two wanted assurance of efficacy before participating in a trial. Conclusion Justification of modes other than tablets/capsules and variable understanding about cannabis and trials will need addressing in trial‐related information to optimise recruitment and ensure that consent is properly informed. Background Australian clinical trials are planned to evaluate medicinal cannabis in a range of clinical contexts. Aims To explore the preferences, attitudes and beliefs of patients eligible and willing to consider participation in a clinical trial of medicinal cannabis for poor appetite and appetite-related symptoms from advanced cancer. Methods A cross-sectional anonymous survey was administered from July to December 2015 online and in eight adult outpatient palliative care and/or cancer services. Respondents were eligible if they were greater than or equal to 18years, had advanced cancer and poor appetite/taste problems/weight loss and might consider participating in a medicinal cannabis trial. Survey items focused on medicinal rather than recreational cannabis use and did not specify botanical or pharmaceutical products. Items asked about previous medicinal cannabis use and preferences for delivery route and invited comments and concerns. Results There were 204 survey respondents, of whom 26 (13%) reported prior medicinal cannabis use. Tablets/capsules were the preferred delivery mode (n=144, 71%), followed by mouth spray (n=84, 42%) and vaporiser (n=83, 41%). Explanations for preferences (n=134) most commonly cited convenience (n=66; 49%). A total of 82% (n=168) of respondents indicated that they had no trial-related concerns, but a small number volunteered concerns about adverse effects (n=14) or wanted more information/advice (n=8). Six respondents volunteered a belief that cannabis might cure cancer, while two wanted assurance of efficacy before participating in a trial. Conclusion Justification of modes other than tablets/capsules and variable understanding about cannabis and trials will need addressing in trial-related information to optimise recruitment and ensure that consent is properly informed. BACKGROUNDAustralian clinical trials are planned to evaluate medicinal cannabis in a range of clinical contexts.AIMSTo explore the preferences, attitudes and beliefs of patients eligible and willing to consider participation in a clinical trial of medicinal cannabis for poor appetite and appetite-related symptoms from advanced cancer.METHODSA cross-sectional anonymous survey was administered from July to December 2015 online and in eight adult outpatient palliative care and/or cancer services. Respondents were eligible if they were ≥18 years, had advanced cancer and poor appetite/taste problems/weight loss and might consider participating in a medicinal cannabis trial. Survey items focused on medicinal rather than recreational cannabis use and did not specify botanical or pharmaceutical products. Items asked about previous medicinal cannabis use and preferences for delivery route and invited comments and concerns.RESULTSThere were 204 survey respondents, of whom 26 (13%) reported prior medicinal cannabis use. Tablets/capsules were the preferred delivery mode (n = 144, 71%), followed by mouth spray (n = 84, 42%) and vaporiser (n = 83, 41%). Explanations for preferences (n = 134) most commonly cited convenience (n = 66; 49%). A total of 82% (n = 168) of respondents indicated that they had no trial-related concerns, but a small number volunteered concerns about adverse effects (n = 14) or wanted more information/advice (n = 8). Six respondents volunteered a belief that cannabis might cure cancer, while two wanted assurance of efficacy before participating in a trial.CONCLUSIONJustification of modes other than tablets/capsules and variable understanding about cannabis and trials will need addressing in trial-related information to optimise recruitment and ensure that consent is properly informed. Australian clinical trials are planned to evaluate medicinal cannabis in a range of clinical contexts. To explore the preferences, attitudes and beliefs of patients eligible and willing to consider participation in a clinical trial of medicinal cannabis for poor appetite and appetite-related symptoms from advanced cancer. A cross-sectional anonymous survey was administered from July to December 2015 online and in eight adult outpatient palliative care and/or cancer services. Respondents were eligible if they were ≥18 years, had advanced cancer and poor appetite/taste problems/weight loss and might consider participating in a medicinal cannabis trial. Survey items focused on medicinal rather than recreational cannabis use and did not specify botanical or pharmaceutical products. Items asked about previous medicinal cannabis use and preferences for delivery route and invited comments and concerns. There were 204 survey respondents, of whom 26 (13%) reported prior medicinal cannabis use. Tablets/capsules were the preferred delivery mode (n = 144, 71%), followed by mouth spray (n = 84, 42%) and vaporiser (n = 83, 41%). Explanations for preferences (n = 134) most commonly cited convenience (n = 66; 49%). A total of 82% (n = 168) of respondents indicated that they had no trial-related concerns, but a small number volunteered concerns about adverse effects (n = 14) or wanted more information/advice (n = 8). Six respondents volunteered a belief that cannabis might cure cancer, while two wanted assurance of efficacy before participating in a trial. Justification of modes other than tablets/capsules and variable understanding about cannabis and trials will need addressing in trial-related information to optimise recruitment and ensure that consent is properly informed.
Author	McCaffrey, N. Agar, M. Allsop, D. McGregor, I. Luckett, T. Phillips, J. Lovell, M. Currow, D. Aggarwal, R. Lee, J. Chye, R. Solowij, N. Lam, L. Lintzeris, N. Martin, J.
Author_xml	– sequence: 1 givenname: T. surname: Luckett fullname: Luckett, T. email: tim.luckett@uts.edu.au, tim.luckett@uts.edu.au organization: Centre for Cardiovascular and Chronic Care, Faculty of Health, University of Technology Sydney, New South Wales, Sydney, Australia – sequence: 2 givenname: J. surname: Phillips fullname: Phillips, J. organization: Centre for Cardiovascular and Chronic Care, Faculty of Health, University of Technology Sydney, New South Wales, Sydney, Australia – sequence: 3 givenname: N. surname: Lintzeris fullname: Lintzeris, N. organization: Discipline of Addiction Medicine, Central Clinical School, Sydney Medical School, Sydney, New South Wales, Australia – sequence: 4 givenname: D. surname: Allsop fullname: Allsop, D. organization: School of Psychology, The University of Sydney, New South Wales, Sydney, Australia – sequence: 5 givenname: J. surname: Lee fullname: Lee, J. organization: Palliative Care, Concord Repatriation General Hospital, New South Wales, Sydney, Australia – sequence: 6 givenname: N. surname: Solowij fullname: Solowij, N. organization: School of Psychology, University of Wollongong, New South Wales, Wollongong, Australia – sequence: 7 givenname: J. surname: Martin fullname: Martin, J. organization: Department of Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, New South Wales, Newcastle, Australia – sequence: 8 givenname: L. surname: Lam fullname: Lam, L. organization: Centre for Cardiovascular and Chronic Care, Faculty of Health, University of Technology Sydney, New South Wales, Sydney, Australia – sequence: 9 givenname: R. surname: Aggarwal fullname: Aggarwal, R. organization: Palliative Care, Liverpool Cancer Therapy Centre, Liverpool Hospital, New South Wales, Sydney, Australia – sequence: 10 givenname: N. surname: McCaffrey fullname: McCaffrey, N. organization: Palliative and Supportive Services, Flinders University, South Australia, Adelaide, Australia – sequence: 11 givenname: D. surname: Currow fullname: Currow, D. organization: Palliative and Supportive Services, Flinders University, South Australia, Adelaide, Australia – sequence: 12 givenname: R. surname: Chye fullname: Chye, R. organization: Sacred Heart Supportive and Palliative Care, St Vincent's Hospital, New South Wales, Sydney, Australia – sequence: 13 givenname: M. surname: Lovell fullname: Lovell, M. organization: Palliative Care, Greenwich Hospital, HammondCare, Sydney, New South Wales, Australia – sequence: 14 givenname: I. surname: McGregor fullname: McGregor, I. organization: Department of Psychopharmacology, Faculty of Science, The University of Sydney, New South Wales, Sydney, Australia – sequence: 15 givenname: M. surname: Agar fullname: Agar, M. organization: Centre for Cardiovascular and Chronic Care, Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/27530738$$D View this record in MEDLINE/PubMed
BookMark	eNqNkctu1TAQhiNURC-w4AWQlyCR1o4dJ2aHjuihcIBNUZeWY08ql8RObadwHo23w-fGAoGENzOa-f5f45nT4sh5B0XxnOBzkt-FHe_OCa0q9qg4IYzVZS0EO9rmrMQC0-PiNMY7jElDBXtSHFdNTXFD25Pi52Kwzmo1oBSsGiLyPRrBWG1drmnlnOpsRL0PSE0TJJugDDCoBAbF9TglP-Zu8CNS5kE5nct6E8IbpFCcwwOsN5ZTgB4C5EZ8jVTKNrOBiJQzqIPBQp_z0btbNKlkwaWIvtshT3aLkkfau2gNhNwMKU-2Ybx7Wjzu88DwbB_Piq-X764X78vVl-XV4u2q1IxzVjLgfU10I7jRTLRt2wPhlFBumMZEaN1RhikjoubKdKoWhNXaiMrgptGmx_SseLnznYK_nyEmOdqoYRiUAz9HSVrGGc4W9X-glDdVKxqW0Rd7dO7yvuUU7KjCWh4uk4GLHaCDjzGvT2qbth9PQdlBEiw3t5f59nJ7-6x49YfiYPo3du-e1wzrf4Py6tOHg6LcKWxM8OO3QoVvkje0qeXN56W8uW5Xlx-5kEv6C-Xs0GE
CitedBy_id	crossref_primary_10_1111_1467_9566_13684 crossref_primary_10_3390_children11020234 crossref_primary_10_1111_bcp_13671 crossref_primary_10_1177_1078155219843161 crossref_primary_10_1089_pmr_2024_0031 crossref_primary_10_1186_s12904_019_0494_6 crossref_primary_10_1071_AH19066 crossref_primary_10_1089_jpm_2024_0422 crossref_primary_10_1002_cncr_30879 crossref_primary_10_1007_s41669_017_0039_y crossref_primary_10_1177_1758835919866362 crossref_primary_10_1016_j_ctim_2019_102204 crossref_primary_10_1136_bmjspcare_2022_003747 crossref_primary_10_1186_s13063_022_06691_1 crossref_primary_10_1089_jayao_2019_0039 crossref_primary_10_1089_jpm_2018_0533 crossref_primary_10_1111_hex_13642 crossref_primary_10_1186_s13063_020_04541_6 crossref_primary_10_5694_mja17_01247 crossref_primary_10_1089_jpm_2019_0540 crossref_primary_10_1111_imj_14732 crossref_primary_10_1007_s00520_023_07994_y crossref_primary_10_1016_j_jpainsymman_2025_02_009 crossref_primary_10_1111_bcp_13724 crossref_primary_10_1186_s40001_024_01803_w crossref_primary_10_1136_spcare_2022_004035 crossref_primary_10_1089_jpm_2019_0218 crossref_primary_10_1111_imj_15361 crossref_primary_10_1186_s12885_022_09378_7 crossref_primary_10_1007_s00520_023_07662_1 crossref_primary_10_1111_ajco_14149
Cites_doi	10.1017/S0317167100002584 10.1159/000112901 10.1016/s0304-3959(02)00400-1 10.1016/j.amepre.2015.05.027 10.3109/10826084.2010.537732 10.1186/1477-7517-9-12 10.1177/002204260303300204 10.1177/1049909112454215 10.1097/00007611-199702000-00001 10.1016/j.jpain.2012.10.009 10.1016/j.ctcp.2005.09.006 10.1371/journal.pone.0018440 10.5694/mja14.01573 10.1111/j.1467-9566.2012.01476.x 10.1002/j.1552-4604.2002.tb05998.x 10.1016/j.ejpain.2010.12.004 10.1093/annonc/mdq727 10.1200/JCO.1991.9.7.1314 10.1007/s12160-016-9798-4 10.1089/108729104323038892 10.1001/jama.2015.6358 10.1186/1477-7517-2-18 10.1185/03007995.2014.952715 10.1159/000057154 10.1016/j.drugalcdep.2015.12.020
ContentType	Journal Article
Copyright	2016 Royal Australasian College of Physicians 2016 Royal Australasian College of Physicians.
Copyright_xml	– notice: 2016 Royal Australasian College of Physicians – notice: 2016 Royal Australasian College of Physicians.
DBID	BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 H94
DOI	10.1111/imj.13224
DatabaseName	Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts
DatabaseTitleList	AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1445-5994
EndPage	1275
ExternalDocumentID	27530738 10_1111_imj_13224 IMJ13224 ark_67375_WNG_WT8LFK69_G
Genre	article Journal Article
GrantInformation_xml	– fundername: University of Technology Sydney
GroupedDBID	--- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 29J 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AIACR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M J5H K48 KBYEO KTM LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K RJQFR ROL RX1 SUPJJ TEORI UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOQ WOW WQJ WVDHM WXI WXSBR XG1 YFH ZGI ZZTAW ~IA ~WT AAHHS ACCFJ ADZOD AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE ESX WRC AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 H94
ID	FETCH-LOGICAL-c4664-4e6f51c796dc49888fe163136d4c019ccb340341956adba59145cd92d077cdf03
IEDL.DBID	DR2
ISSN	1444-0903
IngestDate	Fri Sep 05 03:31:13 EDT 2025 Thu Sep 04 18:33:45 EDT 2025 Thu Apr 03 07:13:04 EDT 2025 Tue Jul 01 03:45:00 EDT 2025 Thu Apr 24 23:08:52 EDT 2025 Wed Jan 22 16:47:12 EST 2025 Sun Sep 21 06:18:44 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	11
Keywords	clinical trial cannabis cancer anorexia attitude
Language	English
License	2016 Royal Australasian College of Physicians.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c4664-4e6f51c796dc49888fe163136d4c019ccb340341956adba59145cd92d077cdf03
Notes	University of Technology Sydney ark:/67375/WNG-WT8LFK69-G ArticleID:IMJ13224 istex:3E6411C57D5CAE02891835EA35CE763C86679847 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
PMID	27530738
PQID	1836728974
PQPubID	23479
PageCount	7
ParticipantIDs	proquest_miscellaneous_1846400345 proquest_miscellaneous_1836728974 pubmed_primary_27530738 crossref_citationtrail_10_1111_imj_13224 crossref_primary_10_1111_imj_13224 wiley_primary_10_1111_imj_13224_IMJ13224 istex_primary_ark_67375_WNG_WT8LFK69_G
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	2016-11 November 2016 2016-11-00 2016-Nov 20161101
PublicationDateYYYYMMDD	2016-11-01
PublicationDate_xml	– month: 11 year: 2016 text: 2016-11
PublicationDecade	2010
PublicationPlace	Melbourne
PublicationPlace_xml	– name: Melbourne – name: Australia
PublicationTitle	Internal medicine journal
PublicationTitleAlternate	Intern Med J
PublicationYear	2016
Publisher	John Wiley & Sons Australia, Ltd
Publisher_xml	– name: John Wiley & Sons Australia, Ltd
References	Brisbois TD , de Kock IH , Watanabe SM , Mirhosseini M , Lamoureux DC , Chasen M et al. Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol 2011; 22: 2086-2093. Pedersen W , Sandberg S . The medicalisation of revolt: a sociological analysis of medical cannabis users. Sociol Health Illn 2013; 35: 17-32. Whiting PF , Wolff RF , Deshpande S , Di Nisio M , Duffy S , Hernandez AV et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015; 313: 2456-2473. Janichek JL , Reiman A . Clinical service desires of medical cannabis patients. Harm Reduct J 2012; 9: 12. Swift W , Gates P , Dillon P . Survey of Australians using cannabis for medical purposes. Harm Reduct J 2005; 2: 18. Page SA , Verhoef MJ , Stebbins RA , Metz LM , Levy JC . Cannabis use as described by people with multiple sclerosis. Can J Neurol Sci 2003; 30: 201-205. Fiz J , Duran M , Capella D , Carbonell J , Farre M . Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life. PLoS One 2011; 6: e18440. Australian Institute of Health and Welfare. Australian cancer incidence and mortality (ACIM) books: all cancers combined . Canberra: Australian Institute of Health and Welfare; 2016. Penington D . Medical cannabis: time for clear thinking. Med J Aust 2015; 202: 74-75. Doblin RE , Kleiman MA . Marijuana as antiemetic medicine: a survey of oncologists' experiences and attitudes. J Clin Oncol 1991; 9: 1314-1319. Furler MD , Einarson TR , Millson M , Walmsley S , Bendayan R . Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDs 2004; 18: 215-228. Davies A , Zeppetella G , Andersen S , Damkier A , Vejlgaard T , Nauck F et al. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. Eur J Pain 2011; 15: 756-63. Lee DC , Crosier BS , Borodovsky JT , Sargent JD , Budney AJ . Online survey characterizing vaporizer use among cannabis users. Drug Alcohol Depend 2016; 159: 227-233. Australian Institute of Health and Welfare. 2010 national drug strategy household survey report . Canberra: Australian Institute of Health and Welfare; 2011. Ware MA , Doyle CR , Woods R , Lynch ME , Clark AJ . Cannabis use for chronic non-cancer pain: results of a prospective survey. Pain 2003; 102: 211-216. McEachan R , Taylor N , Harrison R , Lawton R , Gardner P , Conner M . Meta-analysis of the reasoned action approach (RAA) to understanding health behaviors. Ann Behav Med 2016; 50: 592-612. Consroe P , Musty R , Rein J , Tillery W , Pertwee R . The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 1997; 38: 44-48. Schauer GL , King BA , Bunnell RE , Promoff G , McAfee TA . Toking, vaping, and eating for health or fun: marijuana use patterns in adults, U.S., 2014. Am J Prev Med 2016; 50: 1-8. Shingler SL , Bennett BM , Cramer JA , Towse A , Twelves C , Lloyd AJ . Treatment preference, adherence and outcomes in patients with cancer: literature review and development of a theoretical model. Curr Med Res Opin 2014; 30: 2329-2341. Coomber R , Oliver M , Morris C . Using cannabis therapeutically in the UK: a qualitative analysis. J Drug Issues 2003; 33: 325-356. Schwartz RH , Voth EA , Sheridan MJ . Marijuana to prevent nausea and vomiting in cancer patients: a survey of clinical oncologists. South Med J 1997; 90: 167-172. Mechoulam R , Parker LA , Gallily R . Cannabidiol: an overview of some pharmacological aspects. J Clin Pharmacol 2002; 42: 11S-9. Wilsey B , Marcotte T , Deutsch R , Gouaux B , Sakai S , Donaghe H . Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain 2013; 14: 136-148. Schnelle M , Grotenhermen F , Reif M , Gorter RW . Results of a standardized survey on the medical use of cannabis products in the German-speaking area. Forsch Komplementarmed 1999; 6(Suppl 3): 28-36. Bottorff JL , Bissell LJ , Balneaves LG , Oliffe JL , Kang HB , Capler NR et al. Health effects of using cannabis for therapeutic purposes: a gender analysis of users' perspectives. Subst Use Misuse 2011; 46: 769-780. Aggarwal SK , Carter GT , Sullivan MD , Zumbrunnen C , Morrill R , Mayer JD . Prospectively surveying health-related quality of life and symptom relief in a lot-based sample of medical cannabis-using patients in urban Washington State reveals managed chronic illness and debility. Am J Hosp Palliat Med 2013; 30: 523-531. Westfall RE , Janssen PA , Lucas P , Capler R . Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness' [reprint in Complement Ther Clin Pract 2009; 15: 242-6]. Complement Ther Clin Pract 2006; 12: 27-33. 2006; 12 2011 2015; 202 2016; 50 2011; 15 1999; 6 2011; 6 2003; 30 1991; 9 2003; 33 1997; 90 2013; 14 2004; 18 2015; 313 2002; 42 2013; 35 2013; 30 2011; 22 1997; 38 2011; 46 2016 2016; 159 2005; 2 2014; 30 2003; 102 2012; 9 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_3_1 Australian Institute of Health and Welfare (e_1_2_7_4_1) 2011 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_24_1 e_1_2_7_23_1 e_1_2_7_22_1 e_1_2_7_21_1 e_1_2_7_20_1 Australian Institute of Health and Welfare (e_1_2_7_31_1) 2016
References_xml	– reference: Consroe P , Musty R , Rein J , Tillery W , Pertwee R . The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 1997; 38: 44-48. – reference: Schwartz RH , Voth EA , Sheridan MJ . Marijuana to prevent nausea and vomiting in cancer patients: a survey of clinical oncologists. South Med J 1997; 90: 167-172. – reference: Bottorff JL , Bissell LJ , Balneaves LG , Oliffe JL , Kang HB , Capler NR et al. Health effects of using cannabis for therapeutic purposes: a gender analysis of users' perspectives. Subst Use Misuse 2011; 46: 769-780. – reference: Wilsey B , Marcotte T , Deutsch R , Gouaux B , Sakai S , Donaghe H . Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain 2013; 14: 136-148. – reference: Australian Institute of Health and Welfare. Australian cancer incidence and mortality (ACIM) books: all cancers combined . Canberra: Australian Institute of Health and Welfare; 2016. – reference: Davies A , Zeppetella G , Andersen S , Damkier A , Vejlgaard T , Nauck F et al. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. Eur J Pain 2011; 15: 756-63. – reference: McEachan R , Taylor N , Harrison R , Lawton R , Gardner P , Conner M . Meta-analysis of the reasoned action approach (RAA) to understanding health behaviors. Ann Behav Med 2016; 50: 592-612. – reference: Doblin RE , Kleiman MA . Marijuana as antiemetic medicine: a survey of oncologists' experiences and attitudes. J Clin Oncol 1991; 9: 1314-1319. – reference: Page SA , Verhoef MJ , Stebbins RA , Metz LM , Levy JC . Cannabis use as described by people with multiple sclerosis. Can J Neurol Sci 2003; 30: 201-205. – reference: Swift W , Gates P , Dillon P . Survey of Australians using cannabis for medical purposes. Harm Reduct J 2005; 2: 18. – reference: Schauer GL , King BA , Bunnell RE , Promoff G , McAfee TA . Toking, vaping, and eating for health or fun: marijuana use patterns in adults, U.S., 2014. Am J Prev Med 2016; 50: 1-8. – reference: Coomber R , Oliver M , Morris C . Using cannabis therapeutically in the UK: a qualitative analysis. J Drug Issues 2003; 33: 325-356. – reference: Whiting PF , Wolff RF , Deshpande S , Di Nisio M , Duffy S , Hernandez AV et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015; 313: 2456-2473. – reference: Australian Institute of Health and Welfare. 2010 national drug strategy household survey report . Canberra: Australian Institute of Health and Welfare; 2011. – reference: Mechoulam R , Parker LA , Gallily R . Cannabidiol: an overview of some pharmacological aspects. J Clin Pharmacol 2002; 42: 11S-9. – reference: Schnelle M , Grotenhermen F , Reif M , Gorter RW . Results of a standardized survey on the medical use of cannabis products in the German-speaking area. Forsch Komplementarmed 1999; 6(Suppl 3): 28-36. – reference: Lee DC , Crosier BS , Borodovsky JT , Sargent JD , Budney AJ . Online survey characterizing vaporizer use among cannabis users. Drug Alcohol Depend 2016; 159: 227-233. – reference: Janichek JL , Reiman A . Clinical service desires of medical cannabis patients. Harm Reduct J 2012; 9: 12. – reference: Furler MD , Einarson TR , Millson M , Walmsley S , Bendayan R . Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDs 2004; 18: 215-228. – reference: Fiz J , Duran M , Capella D , Carbonell J , Farre M . Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life. PLoS One 2011; 6: e18440. – reference: Pedersen W , Sandberg S . The medicalisation of revolt: a sociological analysis of medical cannabis users. Sociol Health Illn 2013; 35: 17-32. – reference: Brisbois TD , de Kock IH , Watanabe SM , Mirhosseini M , Lamoureux DC , Chasen M et al. Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol 2011; 22: 2086-2093. – reference: Ware MA , Doyle CR , Woods R , Lynch ME , Clark AJ . Cannabis use for chronic non-cancer pain: results of a prospective survey. Pain 2003; 102: 211-216. – reference: Shingler SL , Bennett BM , Cramer JA , Towse A , Twelves C , Lloyd AJ . Treatment preference, adherence and outcomes in patients with cancer: literature review and development of a theoretical model. Curr Med Res Opin 2014; 30: 2329-2341. – reference: Aggarwal SK , Carter GT , Sullivan MD , Zumbrunnen C , Morrill R , Mayer JD . Prospectively surveying health-related quality of life and symptom relief in a lot-based sample of medical cannabis-using patients in urban Washington State reveals managed chronic illness and debility. Am J Hosp Palliat Med 2013; 30: 523-531. – reference: Westfall RE , Janssen PA , Lucas P , Capler R . Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness' [reprint in Complement Ther Clin Pract 2009; 15: 242-6]. Complement Ther Clin Pract 2006; 12: 27-33. – reference: Penington D . Medical cannabis: time for clear thinking. Med J Aust 2015; 202: 74-75. – year: 2011 – volume: 50 start-page: 592 year: 2016 end-page: 612 article-title: Meta‐analysis of the reasoned action approach (RAA) to understanding health behaviors publication-title: Ann Behav Med – volume: 313 start-page: 2456 year: 2015 end-page: 2473 article-title: Cannabinoids for medical use: a systematic review and meta‐analysis publication-title: JAMA – volume: 12 start-page: 27 year: 2006 end-page: 33 article-title: Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self‐assessment of its efficacy against 'morning sickness' [reprint in 2009; 15: 242–6] publication-title: Complement Ther Clin Pract – volume: 14 start-page: 136 year: 2013 end-page: 148 article-title: Low‐dose vaporized cannabis significantly improves neuropathic pain publication-title: J Pain – volume: 159 start-page: 227 year: 2016 end-page: 233 article-title: Online survey characterizing vaporizer use among cannabis users publication-title: Drug Alcohol Depend – volume: 202 start-page: 74 year: 2015 end-page: 75 article-title: Medical cannabis: time for clear thinking publication-title: Med J Aust – volume: 2 start-page: 18 year: 2005 article-title: Survey of Australians using cannabis for medical purposes publication-title: Harm Reduct J – volume: 9 start-page: 1314 year: 1991 end-page: 1319 article-title: Marijuana as antiemetic medicine: a survey of oncologists' experiences and attitudes publication-title: J Clin Oncol – year: 2016 – volume: 90 start-page: 167 year: 1997 end-page: 172 article-title: Marijuana to prevent nausea and vomiting in cancer patients: a survey of clinical oncologists publication-title: South Med J – volume: 50 start-page: 1 year: 2016 end-page: 8 article-title: Toking, vaping, and eating for health or fun: marijuana use patterns in adults, U.S., 2014 publication-title: Am J Prev Med – volume: 6 start-page: 28 year: 1999 end-page: 36 article-title: Results of a standardized survey on the medical use of cannabis products in the German‐speaking area publication-title: Forsch Komplementarmed – volume: 30 start-page: 2329 year: 2014 end-page: 2341 article-title: Treatment preference, adherence and outcomes in patients with cancer: literature review and development of a theoretical model publication-title: Curr Med Res Opin – volume: 9 start-page: 12 year: 2012 article-title: Clinical service desires of medical cannabis patients publication-title: Harm Reduct J – volume: 46 start-page: 769 year: 2011 end-page: 780 article-title: Health effects of using cannabis for therapeutic purposes: a gender analysis of users' perspectives publication-title: Subst Use Misuse – volume: 22 start-page: 2086 year: 2011 end-page: 2093 article-title: Delta‐9‐tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double‐blind, placebo‐controlled pilot trial publication-title: Ann Oncol – volume: 33 start-page: 325 year: 2003 end-page: 356 article-title: Using cannabis therapeutically in the UK: a qualitative analysis publication-title: J Drug Issues – volume: 35 start-page: 17 year: 2013 end-page: 32 article-title: The medicalisation of revolt: a sociological analysis of medical cannabis users publication-title: Sociol Health Illn – volume: 18 start-page: 215 year: 2004 end-page: 228 article-title: Medicinal and recreational marijuana use by patients infected with HIV publication-title: AIDS Patient Care STDs – volume: 102 start-page: 211 year: 2003 end-page: 216 article-title: Cannabis use for chronic non‐cancer pain: results of a prospective survey publication-title: Pain – volume: 30 start-page: 201 year: 2003 end-page: 205 article-title: Cannabis use as described by people with multiple sclerosis publication-title: Can J Neurol Sci – volume: 6 start-page: e18440 year: 2011 article-title: Cannabis use in patients with fibromyalgia: effect on symptoms relief and health‐related quality of life publication-title: PLoS One – volume: 30 start-page: 523 year: 2013 end-page: 531 article-title: Prospectively surveying health‐related quality of life and symptom relief in a lot‐based sample of medical cannabis‐using patients in urban Washington State reveals managed chronic illness and debility publication-title: Am J Hosp Palliat Med – volume: 38 start-page: 44 year: 1997 end-page: 48 article-title: The perceived effects of smoked cannabis on patients with multiple sclerosis publication-title: Eur Neurol – volume: 15 start-page: 756 year: 2011 end-page: 63 article-title: Multi‐centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies publication-title: Eur J Pain – volume: 42 start-page: 11S year: 2002 end-page: 9 article-title: Cannabidiol: an overview of some pharmacological aspects publication-title: J Clin Pharmacol – ident: e_1_2_7_8_1 doi: 10.1017/S0317167100002584 – ident: e_1_2_7_6_1 doi: 10.1159/000112901 – ident: e_1_2_7_9_1 doi: 10.1016/s0304-3959(02)00400-1 – ident: e_1_2_7_14_1 doi: 10.1016/j.amepre.2015.05.027 – ident: e_1_2_7_15_1 doi: 10.3109/10826084.2010.537732 – ident: e_1_2_7_27_1 doi: 10.1186/1477-7517-9-12 – ident: e_1_2_7_26_1 doi: 10.1177/002204260303300204 – ident: e_1_2_7_24_1 doi: 10.1177/1049909112454215 – ident: e_1_2_7_3_1 – ident: e_1_2_7_29_1 doi: 10.1097/00007611-199702000-00001 – ident: e_1_2_7_22_1 doi: 10.1016/j.jpain.2012.10.009 – ident: e_1_2_7_12_1 doi: 10.1016/j.ctcp.2005.09.006 – ident: e_1_2_7_13_1 doi: 10.1371/journal.pone.0018440 – ident: e_1_2_7_2_1 doi: 10.5694/mja14.01573 – ident: e_1_2_7_25_1 doi: 10.1111/j.1467-9566.2012.01476.x – ident: e_1_2_7_17_1 doi: 10.1002/j.1552-4604.2002.tb05998.x – ident: e_1_2_7_19_1 doi: 10.1016/j.ejpain.2010.12.004 – ident: e_1_2_7_16_1 – ident: e_1_2_7_20_1 doi: 10.1093/annonc/mdq727 – ident: e_1_2_7_21_1 – ident: e_1_2_7_28_1 doi: 10.1200/JCO.1991.9.7.1314 – ident: e_1_2_7_30_1 doi: 10.1007/s12160-016-9798-4 – ident: e_1_2_7_10_1 doi: 10.1089/108729104323038892 – volume-title: Australian cancer incidence and mortality (ACIM) books: all cancers combined year: 2016 ident: e_1_2_7_31_1 – volume-title: 2010 national drug strategy household survey report year: 2011 ident: e_1_2_7_4_1 – ident: e_1_2_7_5_1 doi: 10.1001/jama.2015.6358 – ident: e_1_2_7_11_1 doi: 10.1186/1477-7517-2-18 – ident: e_1_2_7_18_1 doi: 10.1185/03007995.2014.952715 – ident: e_1_2_7_7_1 doi: 10.1159/000057154 – ident: e_1_2_7_23_1 doi: 10.1016/j.drugalcdep.2015.12.020
SSID	ssj0017394
Score	2.3041024
Snippet	Background Australian clinical trials are planned to evaluate medicinal cannabis in a range of clinical contexts. Aims To explore the preferences, attitudes... Australian clinical trials are planned to evaluate medicinal cannabis in a range of clinical contexts. To explore the preferences, attitudes and beliefs of... BACKGROUNDAustralian clinical trials are planned to evaluate medicinal cannabis in a range of clinical contexts.AIMSTo explore the preferences, attitudes and... Background Australian clinical trials are planned to evaluate medicinal cannabis in a range of clinical contexts. Aims To explore the preferences, attitudes...
SourceID	proquest pubmed crossref wiley istex
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	1269
SubjectTerms	Adolescent Adult Aged Aged, 80 and over anorexia Anorexia - drug therapy Appetite - drug effects attitude Australia cancer cannabis clinical trial Clinical Trials as Topic Cross-Sectional Studies Female Health Knowledge, Attitudes, Practice Humans Logistic Models Male Medical Marijuana - administration & dosage Medical Marijuana - therapeutic use Middle Aged Neoplasms - complications Patient Participation Patient Preference Self Report Young Adult
Title	Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation
URI	https://api.istex.fr/ark:/67375/WNG-WT8LFK69-G/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fimj.13224 https://www.ncbi.nlm.nih.gov/pubmed/27530738 https://www.proquest.com/docview/1836728974 https://www.proquest.com/docview/1846400345
Volume	46
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELaqIiEu_EOXPxmEEAdS7SaOvYYTAralsD2gVu0ByXL8I63aTaI4C5QTj8D78DY8CWPHiVpUEOIWbca78c6M55t4_A1Cj1WmU5tSnhjKioTkcppIa3VCuISALeXYhJL_-S7d3ic7h_nhGnrRn4Xp-CGGF27eM8J67R1cFu6Uky-WvkYLIhCsv5OMet781x8G6qgJy0ITRMgXSHgXEVmFfBXPMPJMLLrg_9Yv5wHNs7g1BJ7ZFfSxf-Su3uRoc9UWm-rrb2yO_zmnq-hyBKT4ZWdB19CaKa-ji_O45X4D_YjMocc4NPhwuLI4bsjDZ6CYUhYLhwH7YlnX_sya-fntezgiYzR2J8u6rZZwv6mWuC848MOUaZ5jid2q-WRO_JfWQ8cT9wzL1pcwaOOwLDUuYFrGwrXvjIQjFazDnxeBUBy3FVax7yjcPFUnfhPtz97svdpOYseHRHma-4QYavOJYpxqRTgk59YAXgTtaqIAiypVZGTsGehyKnUhcz4hudI81WPGlLbj7BZaL6vSbCBMuZGQi0LwtZzwFDI1plRGFYwBVEXVCD3tdS9UpEP3XTmORZ8WgTJEUMYIPRpE644D5DyhJ8GABgnZHPmiOZaLg90tcbA3fT97R7nYGqGHvYUJcGW_PyNLU62cgNWVMkiAGfmbDKHEkwrlI3S7M8_hF1NIPWHFnsLUgpH9-WHF2_lOuLjz76J30SUAi7Q7h3kPrbfNytwHQNYWD4Ln_QJHDzSb
linkProvider	Wiley-Blackwell
linkToHtml	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VVgIu5Z8uvwYhxIFUu4njrBEXhNhu2909oK3aS2U5tiOt2k2iJAuUE4_A-_A2PAlj50ctKghxizbjJF7PeL6xx98AvFCB9hOfcc-wKPZoKIeeTBLtUS7RYUvZNy7lfzpj4wO6dxQercHb9ixMzQ_RLbhZy3DztTVwuyB9zsoXS5ukhS7oCmy4_TkLiT525FGDKHBlEDFioG41ouEVsnk8XdML3mjD_rFfLoOaF5Grcz2jG3DcfnSdcXKyvaribfX1Nz7H_-3VTdhsMCl5VyvRLVgz6W24Om123e_Aj4Y89JS4Gh8lyRLS7Mnjbzg2qYwXJUH4S2Se22Nr5ue37-6UjNGkPFvmVbbE-0W2JG3OgW2mTPGGSFKuik_mzD4074qelK-JrGwWgzYlkakmMfbLJHhtiyORhg22JJ8XjlOcVBlRTelRvHkuVfwuHIw-zN-Pvabog6cs071HDUvCgYo404pyjM8Tg5BxEDBNFcJRpeKA9i0JXcikjmXIBzRUmvu6H0VKJ_3gHqynWWq2gDBuJIaj6H8TTrmPwVqkVMAUtkFgxVQPXrWDL1TDiG4Lc5yKNjLCwRBuMHrwvBPNaxqQy4ReOg3qJGRxYvPmolAcznbE4Xw4Ge0zLnZ68KxVMYHWbLdoZGqyVSlwgmURxsAR_ZsMarvlFQp7cL_Wz-6NPkafOGkPsWtOy_78sWJ3uucuHvy76FO4Np5PJ2KyO9t_CNcRO7L6WOYjWK-KlXmM-KyKnzgz_AVtGji5
linkToPdf	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwEB2VVqp4odxZysUghHgg1e7GcdbwhIDtdVcItWofKlmOL9Kq3SRKskB54hP4H_6GL2HsXNSighBvUTJO4njGcyYenwF4pkI9tEPGA8PiJKCRHAXSWh1QLtFhS9k3PuV_MmVbB3TnKDpagtftXpiaH6L74eYsw8_XzsBzbc8Z-WzucrTQA12BFcrQTTpE9LHjjhrEoa-CiAED9T8jGlohl8bTNb3gjFbcd_1yGdK8CFy95xmvwXH7znXCycnGoko21Nff6Bz_s1PX4VqDSMmbWoVuwJJJb8LqpFlzvwU_GurQU-IrfJQks6RZkcdzODKpTGYlQfBLZJ67TWvm57fvfo-M0aQ8m-dVNsfrRTYnbcaBa6ZM8YpIUi6KT-bM3TTvSp6UL4msXA6DNiWRqSYJdstYPHalkUjDBVuSzzPPKE6qjKim8ChePJcofhsOxu_3324FTcmHQDme-4AaZqOBijnTinKMzq1BwDgImaYKwahSSUj7joIuYlInMuIDGinNh7ofx0rbfngHltMsNfeAMG4kBqPofS2nfIihWqxUyBS2QVjFVA9etGMvVMOH7spynIo2LsLBEH4wevC0E81rEpDLhJ57BeokZHHisubiSBxON8Xh_mhvvMu42OzBk1bDBNqyW6CRqckWpcDplcUYAcf0bzKUUccqFPXgbq2e3ROHGHvilD3Crnkl-_PLiu3Jjj-4_--ij2H1w7ux2Nue7q7DVQSOrN6T-QCWq2JhHiI4q5JH3gh_AaH3N2g
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+trials+of+medicinal+cannabis+for+appetite%E2%80%90related+symptoms+from+advanced+cancer%3A+a+survey+of+preferences%2C+attitudes+and+beliefs+among+patients+willing+to+consider+participation&rft.jtitle=Internal+medicine+journal&rft.au=Luckett%2C+T.&rft.au=Phillips%2C+J.&rft.au=Lintzeris%2C+N.&rft.au=Allsop%2C+D.&rft.date=2016-11-01&rft.issn=1444-0903&rft.eissn=1445-5994&rft.volume=46&rft.issue=11&rft.spage=1269&rft.epage=1275&rft_id=info:doi/10.1111%2Fimj.13224&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_imj_13224
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1444-0903&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1444-0903&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1444-0903&client=summon